How major US stock indexes fared Monday, 7/7/2025
The S&P 500 lost 0.8% Monday. The Dow Jones Industrial Average gave back 0.9%, and the Nasdaq composite fell 0.9%.
Tesla tumbled as the feud between CEO Elon Musk and President Donald Trump reignited over the weekend. Musk, once a top donor and ally of Trump, said he would form a third political party in protest over the Republican spending bill that passed last week.
On Monday:
The S&P 500 fell 49.37 points, or 0.8%, to 6,229.98.
The Dow Jones Industrial Average fell 422.17 points, or 0.9%, to 44,406.36.
The Nasdaq composite fell 188.59 points, or 0.9%, to 20,412.52.
The Russell 2000 index of smaller companies fell 34.81 points, or 1.5%, to 2,214.23.
For the year:
The S&P 500 is up 348.35 points, or 5.9%.
The Dow is up 1,862.14 points, or 4.4%.
The Nasdaq is up 1,101.72 points, or 5.7%.
The Russell 2000 is down 15.93 points, or 0.7%.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
10 minutes ago
- Globe and Mail
Top Analyst Reports for T-Mobile, AstraZeneca & Comcast
Tuesday, July 8, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), AstraZeneca PLC (AZN) and Comcast Corp. (CMCSA). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today's research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning. You can read today's AWS here >>> Pre-Markets Mixed at Start of Prime Day, Awaiting Trade Deals Today's Featured Research Reports T-Mobile's shares have outperformed the Zacks Wireless National industry over the past year (+34.5% vs. +30.7%). The company is benefiting from industry-leading postpaid customer growth with a record-low churn rate. Its acquisition strategy has significantly strengthened its position in the wireless industry over the past few years. TMUS' 2.5 GHz 5G spectrum delivers superfast speeds and extensive coverage with signals that go through walls and trees. This boosts its competitive edge against companies that provide 5G networks controlled by the mmWave spectrum. However, owing to the stock's premium valuation, we believe investors should remain cautious as macroeconomic factors, market saturation, or economic downturns can significantly impact overvalued stocks like TMUS. Fierce competition is straining profitability. To lure customers from competitors, T-Mobile has launched several low-priced service plans for consumers. This has put pressure on profits. (You can read the full research report on T-Mobile here >>>) Shares of AstraZeneca have outperformed the Zacks Medical - Biomedical and Genetics industry over the year-to-date period (+7.7% vs. -2%). The company's key drugs like Lynparza, Tagrisso, Imfinzi and Fasenra should keep driving revenues. Its pipeline is strong, with pivotal late- and mid-stage pipeline data readouts lined up. AstraZeneca has also been engaged in external acquisitions and strategic collaborations to boost its pipeline. AstraZeneca believes it can post industry-leading top-line growth in the 2025-2030 period. However, potentially lower sales of Lynparza and Farxiga in China, the impact of Part D redesign on U.S. oncology sales and slowing sales of rare disease drugs are expected to hurt the top line in 2025. Estimates have declined slightly ahead of the Q2 earnings release. The company has a mixed record of earnings surprises in recent quarters. (You can read the full research report on AstraZeneca here >>>) Comcast's shares have underperformed the Zacks Cable Television industry over the year-to-date period (-3.1% vs. +4.2%). The company has been persistently suffering from video-subscriber attrition due to cord-cutting. Broadband prospects are suffering from increased competition from fixed wireless and fiber businesses. Theme Parks revenues declined due to lower revenues at domestic theme parks, driven by lower guest attendance, including the impact of the Hollywood wildfires. A leveraged balance sheet is a major concern for Comcast. Nevertheless, steady growth in Content & Experiences revenues driven by steady performances by Studios and Media segments is positive. Its streaming service, Peacock, has been a key catalyst in driving broadband sales. Decreasing programming & production costs bode well for CMCSA's profitability. Strong free cash flow generation ability is noteworthy. (You can read the full research report on Comcast here >>>) Other noteworthy reports we are featuring today include Entergy Corp. (ETR), Align Technology, Inc. (ALGN) and Universal Health Services, Inc. (UHS). Mark Vickery Senior Editor Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read T-Mobile (TMUS) Rides on Solid 5G Expansion, Strong Cash Flow Key Drugs Aid AstraZeneca (AZN) Sales, Pipeline Strong Domestic Wireless Subscriber Gain Benefits Comcast (CMCSA) Featured Reports Investments Aid ETR Corporation (ETR) Amid Poor Solvency Per the Zacks analyst, ETR Corp. makes disciplined investment to maintain and upgrade the reliability of its electric utility systems. Yet its poor financial ratios indicate weak solvency position. Align (ALGN) Rides on Growing Invisalign Volume, Innovation The Zacks analyst is optimistic about Align's strong market rollout of several Invisalign products globally. The company's focused efforts to expand portfolio aids growth. Rising Admissions Aid Universal Health (UHS), High Costs Ail Per the Zacks analyst, Universal Health's continued growth in admissions at its acute care facilities will boost its top line. However, escalating expenses remain a concern for the company. Strong SMB clientele Aids BILL Holdings' (BILL) Prospects Per the Zacks analyst, BILL is benefiting from an expanding small and medium business (SMB) clientele, as well as a diversified business model. Expanding Customer Base & Smart Investment Aid ONE Gas (OGS) Per the Zacks analyst, ONE Gas is set to benefit from capital expenditure plan and extension of services to new areas. Steady demand from residential customers boosts its performance. Business Growth Plans Aid Boise Cascade (BCC), Macro Risks Ail Per the Zacks analyst, Boise Cascade is gaining from accretive business growth strategies, while ensuring shareholder value. However, housing market softness and macro risks hurt prospects. Sarepta (SRPT) Growth Outlook Dimmed by Elevidys Concerns Though Sarepta's pipeline of LGMD therapies holds potential, the Zacks analyst is concerned with two Elevidys-linked deaths and their impact on topline growth. New Upgrades Loan Growth & Strong Liquidity Supports SouthState (SSB) Per the Zacks analyst, SouthState's expanding loan balance and solid non-interest income will aid top-line growth. Its strong liquidity position enables sustainable capital distributions. SkyWest (SKYW) Benefits From Improving Air-Travel Demand The Zacks Analyst is impressed with the fact that increased air-travel demand is helping SkyWest carry more passengers and witness more revenues. TreeHouse Foods (THS) Drives Growth with Supply Chain Wins Per the Zacks analyst, TreeHouse Foods accelerates margin expansion with supply chain efficiencies, streamlined operations, and a focused portfolio in high-growth private label categories. New Downgrades Expected Decline in Sales & High Capex to Ail Magna (MGA) Per the Zacks analyst, Magna's 2025 revenues are expected to decline due to lower light vehicle production in North America. High capex requirement is likely to strain near-term cash flows. Trucking Costs & Oil Price Swings to Ail Vista Energy (VIST) Per the Zacks analyst, Vista Energy's heavy reliance on trucking for transporting production and its exposure to volatile international oil prices are expected to weigh on its profitability. Weak Digital Sales Hurts Bath & Body Works' (BBWI) Growth Per the Zacks analyst, despite favorable foot traffic, BBWI's digital softness in first quarter suggests cracks in its e-commerce strategy that could weigh on future performance. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren't winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%. See Our Top Stock to Double (Plus 4 Runners Up) >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report Entergy Corporation (ETR): Free Stock Analysis Report Comcast Corporation (CMCSA): Free Stock Analysis Report Universal Health Services, Inc. (UHS): Free Stock Analysis Report Align Technology, Inc. (ALGN): Free Stock Analysis Report T-Mobile US, Inc. (TMUS): Free Stock Analysis Report
CTV News
21 minutes ago
- CTV News
Stanley Park Train won't return this year, and maybe never will
The beloved and beleaguered Stanley Park Train will remain closed for the rest of the year. The beloved and beleaguered Stanley Park Train will officially remain off the tracks for the rest of 2025 – meaning no Halloween or Christmas route – and the City of Vancouver is deliberating the future of the attraction. The 1960s-era locomotive was halted early last holiday season after a worker got sick from exhaust fumes, adding to a long list of reasons the attraction has operated only sporadically over the past five years, including mechanical problems, the pandemic, and coyotes. In a presentation to the Vancouver Board of Parks and Recreation Monday, staff said the train is at the end of its life, and therefore repairs are becoming more frequent and expensive. The Stanley Park Train lost $2.9 million from 2019 to 2024 and about $700,000 this year, according to the report. The situation as it stands poses safety, financial, reputational, and operational risks, the park board heard. Staff presented three possible options for the future of the site on Monday, which include electrifying and fixing the current train, replacing the train and its tracks, and creating a new attraction entirely with a third-party partner. 'Preliminary analysis shows that a full renewal of the train and the ancillary buildings and amenities could require substantial capital investment,' reads a Tuesday news release from the City of Vancouver. 'Alternative operating models, including some form of partnership or third-party operation could lead to a revitalized, reimagined attraction that would reduce the reliance on tax dollars to return the site to operation.' Fixing or replacing the train would cost about $8 million and would garner the lowest financial returns, staff told the board. Meanwhile, the report said the city has received 'multiple proposals' from businesses to build something new, and claimed that would lead to more revenue and more visitors, including tourists. Park Board Commissioner Scott Jensen told CTV News he'd most like to see the train remain in Stanley Park, but will keep an open mind and wants to hear what residents prefer. The presentation indicated ticket prices at an externally operated site could go up to $45. Staff anticipate an increase in prices if the attraction remains at the status quo as well, up to $20. 'I would want to look at what is going to be the best fit for that space that lets the most people have access to it, you know, some parks should not be for some and exclude others,' Jensen said. The specifics of keeping the train in action or remaking the site with a new business model remain up in the air. Consultation on the options is expected to begin this quarter and a call for expression of interest will launch later this year. Park board staff are expected to present further findings in early 2026. 'As part of their report, staff will bring forward proposed strategies for engaging key interest holders and the public, as appropriate, on any changes to the train and its site,' the city's statement reads.
The Market Online
26 minutes ago
- The Market Online
@ the Bell: Trump targets BRICS allies and key trade partners with tariff warnings
Canada's main stock index lost ground on Tuesday as investors weighed new tariff threats from US President Donald Trump and looming deadlines for international trade agreements. On Monday, Trump issued letters to 14 countries—including Japan and South Korea—warning of steep tariff hikes on US imports, though he delayed their enforcement until August 1st. Canada, which recently scrapped its proposed digital services tax on American tech firms to keep trade negotiations on track, is aiming to finalize a deal by July 21st. Meanwhile, US markets attempted to rebound after a downturn triggered by Trump's latest trade measures. The president also floated the possibility of an additional 10 per cent tariff on nations that support what he described as the 'Anti-American policies' of the BRICS bloc, which includes Brazil, Russia, India, and China. The Canadian dollar traded for 73.12 cents US compared to 73.18 cents US on Monday. US crude futures traded $0.41 higher at US$68.34 a barrel, and the Brent contract rose $0.57 to US$70.15 a barrel. The price of gold was down US30.11 to US$3,302.66. In world markets, the Nikkei was up 101.13 points to ¥39,688.81, the Hang Seng was up 260.24 points to HK$24,148.07, the FTSE was up 47.65 points to ₤8,854.18, and the DAX was up 133.24 points to €24,206.91. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
